Company / Total Debt
Phathom Pharmaceuticals, Inc. Total Debt History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$209.1M
FY2025
5-year range
$89.7M / $209.1M
FY2021-FY2025
Trend
+3.8%
vs FY2024
Sector context
#45 of 83
Health Care
What the data says
At $209M, Phathom Pharmaceuticals, Inc.'s total debt ranks #39 of 83 in the Health Care sector. Total Debt has increased for 6 consecutive years, from $23M in FY2019 to $209M in FY2025.
Based on SEC 10-K filings.
$209M in FY2025 with a 5-year CAGR of +39.5%.
Increased from $138M to $209M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +39.5%
- 10-Year CAGR
- -
Sector benchmark
#39 of 83 in Health CareTop 46% of 83This company $209.1M Sector average $6.2B
▼
-96.6% below sector average
Key checks
Key Insights
- Phathom Pharmaceuticals, Inc.'s total debt has grown for 6 consecutive years.
- 5-year CAGR of +39.5%, indicating consistent growth.
- In FY2025, total debt increased 3.8% year-over-year.
- Ranks #45 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $209.1M | +3.8% |
| FY2024 | $201.4M | +46.1% |
| FY2023 | $137.8M | +44.7% |
| FY2022 | $95.3M | +6.2% |
| FY2021 | $89.7M | +126.2% |
| FY2020 | $39.6M | +74.0% |
| FY2019 | $22.8M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026